Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
YouTube

75° Mostly Cloudy
- Broken Bow, NE (68822)
  Today
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low near 65F. Winds SE at 10 to 15 mph. Chance of rain 70%..
  
  Tonight
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low near 65F. Winds SE at 10 to 15 mph. Chance of rain 70%.
  
  Updated: September 17, 2026 @ 5:11 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
- Legal Notices
Business Directory

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

4.895 +1.235 (+33.74%)

Delayed Quote Updated: 12:42 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

September 25, 2024

Via ACCESSWIRE

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch

September 24, 2024

Via ACCESSWIRE

Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference

September 16, 2024

Via ACCESSWIRE

Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care

September 10, 2024

Via ACCESSWIRE

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference

September 06, 2024

Via ACCESSWIRE

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs

September 05, 2024

Via ACCESSWIRE

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones

September 04, 2024

Via ACCESSWIRE

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

August 27, 2024

Via ACCESSWIRE

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

August 19, 2024

Via ACCESSWIRE

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award

August 20, 2024

Via ACCESSWIRE

JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

JAGX stock results show that Jaguar Health missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Why Jaguar Health (JAGX) Stock Is Down 15% ↗

August 13, 2024

Jaguar Health shares are trading lower by 15.4% during Tuesday's session. The company reported worse-than-expected second-quarter results.

Via Benzinga

Jaguar Health Reports Second Quarter 2024 Financial Results

August 13, 2024

Via ACCESSWIRE

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients

August 12, 2024

Via ACCESSWIRE

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful

August 05, 2024

Via ACCESSWIRE

Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

July 31, 2024

Via ACCESSWIRE

Why Jaguar Health Stock Is Crashing ↗

July 23, 2024

Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoint. Here's a look at the details:

Via Benzinga

Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy

August 02, 2024

Via ACCESSWIRE

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting

August 01, 2024

Via ACCESSWIRE

Gold Moves Higher; Coca-Cola Increases FY24 Forecast ↗

July 23, 2024

Via Benzinga

Why Is Azitra (AZTR) Stock Up 315% Today? ↗

July 23, 2024

Azitra stock is up on Tuesday alongside heavy trading of AZTR shares after it provided investors with an update on new patents.

Via InvestorPlace

Spot Ethereum ETFs: 9 Tickers to Watch as New Funds Start Trading ↗

July 23, 2024

Spot Ethereum ETFs have started trading on Tuesday marking a major milestone for fans of the crypto and Ethereum blockchain.

Via InvestorPlace

Topics ETFs

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 23, 2024

Via Benzinga

Why Is Serve Robotics (SERV) Stock Down Today? ↗

July 23, 2024

Serve Robotics stock is down on Tuesday after the company revealed the pricing of warrants for SERV shares in a private placement.

Via InvestorPlace

Why Is Jaguar Health (JAGX) Stock Down 55% Today? ↗

July 23, 2024

Jaguar Health stock is down on Tuesday as JAGX investors react to failed results from a Phase 3 clinical trial of crofelemer.

Via InvestorPlace

Crude Oil Down 2%; GE Aerospace Earnings Top Views ↗

July 23, 2024

Via Benzinga

US Stocks Edge Higher; General Motors Posts Upbeat Earnings ↗

July 23, 2024

Via Benzinga

Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer

July 23, 2024

Via ACCESSWIRE

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning

July 18, 2024

Via ACCESSWIRE

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)

July 08, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Business
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Pay Your Bill
Classifieds
Promote Your Event
Email Alerts
Place an Ad
Rack Locations
Search
Weather

custercountychief.com
311 South 10th Avenue
Broken Bow, NE 68822
Phone: 308-872-2471
Email: publisher@custercountychief.com

Facebook
Twitter
YouTube

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Broken Bow, NE (68822)

Today

Tonight

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

All News about Jaguar Health, Inc. - Common Stock

Sections

Services

Follow Us